Navigation Links
Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
Date:7/23/2008

e reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Contacts:

GendeLLindheim BioCom Partners

Investors Media

info@peregrineinc.com Barbara Lindheim

(800) 987-8256 (212) 918-4650


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
6. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
7. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., COPENHAGEN, Nov. 19 Danish Pri...n cellulosic ethanol plant in Kalundborg, Denmark,... the world,s first and largest 2nd generation etha...erase enzymes are used in the plant,s innovative p...ivision of Danisco, was the first to market with c...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha... of Tuesday,s Annual Meeting of Shareholders. ,...ated (Nasdaq: SPEX ) elected the following member...
(Date:11/19/2009)... World,s Top Gene Synthesis Com...m (IGSC) to Coordinate Best Practices in Risk Redu...t of Worldwide Gene Synthesis Capacity , ...of the world’s leading gene synthesis compan... a common screening protocol to promote biosecurit...
(Date:11/18/2009)...Security personnel need to be able to find explosi...with them. To aid such searches, the National Inst...port from the Department of Homeland Security, has...ndard Reference Material (SRM) 2905, Trace Particu...ory assay methods, the SRM will be helpful in cali...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4New NIST trace explosives standard slated for homeland security duty 2
... Beam Shaping Device Optimized for Targeting Tumor...actic Radiotherapy and Radiosurgery, PALO ALTO, C...E: VAR ) has received FDA 510(k) clearance for a ... ultra-fine beam shaping,device for radiosurgery. ...inicians to deliver,extremely precise radiosurgica...
...ses Research Effort to Target Drug-Resistant Gram ... PHILADELPHIA, Sept. 18 GlaxoSmithKline (NYSE:,GS... with the Defense,Threat Reduction Agency (DTRA) o...y and develop a new class of antibacterials target... Gram negative hospital pathogens. The,agreement a...
...IA, Sept. 18 Premier Research Group plc (AIM:,PRG...its Vice President,Global Human Resources. Mr. Kee...direction and implementing activities related to m...people and organization in alignment,with the comp...mmented: "We are very pleased to have someone,of S...
Other Biology Technology:Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 2Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 3GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program 2GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program 3Premier Research Appoints Global Head of Human Resources 2
(Date:11/20/2009)...arch report published in the November 2009 issue o... ), scientists show how a family of genes (1-amino... are responsible for production of ethylene. This ... this information lays the foundation for future g... resistant, able to survive and thrive in difficul...
(Date:11/20/2009)...ago, a group of University of Oklahoma researchers...t of the human genome project. Today, the OU Adv... to an international effort to sequence the tomato...ational Science Foundation for plant genomics. , ...e, so improving the tomato and crop yields will im...
(Date:11/20/2009)...question in the origin of biological molecules lik...ions of years ago from simple precursors. Now, in ...in Italy have reconstructed one of the earliest ev...A from individual subunits using nothing but warm ...one of the first biological molecules present, bef...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 21 in 7 Low Income Preschoolers Is Obese 52597 11 in 7 Low Income Preschoolers Is Obese 52597 2UC San Diegos 243 million NSF grant to fund science festivals 9336 1UC San Diegos 243 million NSF grant to fund science festivals 9336 2UC San Diegos 243 million NSF grant to fund science festivals 9336 3Registered Dietitian Reveals Chronic Back Pain Relief through Diet in New Book Cookbook and Diet Program 52595 1Registered Dietitian Reveals Chronic Back Pain Relief through Diet in New Book Cookbook and Diet Program 52595 2
...ension increases blood pressure by activating tiny...creased levels of sodium to be reabsorbed into the...ter have found. The findings shed light on the und...y also help explain why patients with hypertension...m supplements in order to keep their high blood pr...
... first detailed molecular images of a piece of the...grab host cells and initiate the first stages of i... protein grasps its receptor, may help scientists ...s. The information could also be helpful in identi...by novel antiviral drugs or vaccines. , The SARS ...
...arley could lead to improved varieties of the crop...d beer. Scientists funded in part by the Biotechno...RC) are beginning a new programme to uncover key g...different barley varieties. , The research, being ...e, Birmingham University and NIAB, involves almost...
Other Biology News:Enzyme affects hypertension by controlling salt levels in body 2Enzyme affects hypertension by controlling salt levels in body 3Learning how SARS spikes its quarry 2Learning how SARS spikes its quarry 3Whisky fans can drink to crop research 2
...m for fluorescent light due to small pixel size. E... level light in animals or plants in tumor researc...ircadian rhythm, gels and Western blots. NightOWL ...de the light-tight cabinet. This function allows c...
Mouse Anti-Human IFNA13 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-SF3B2 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human UGT2B10 Monoclonal Antibody, Unconjugated, Clone 2D9 from Novus Biologicals
Biology Products: